Erasca
Erasca is a developer of oncology drugs intended to provide precision oncology options.
About Erasca
Erasca develops oncology drugs intended to provide precision oncology options. The company's drugs are being developed through multiple discovery programs for undisclosed targets that are biological drivers of cancer and are pursuing additional opportunities for pipeline expansion through academic and biopharmaceutical collaborations, providing patients with new potential solutions to not just treat but cure cancer. Erasca was founded in 2018 and is headquartered in San Diego, California.
Company Facts
- Headquarters
- San Diego
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- public
- Employees
- c_00101_00250
- Funding Stage
- ipo
- Total Funding
- $854,000,000
- Last Funding Type
- post_ipo_equity
- Last Funding Date
- 2026-01-21
- Website
- erasca.com
Industries & Categories
Biotechnology, Life Science, Oncology, Pharmaceutical
Social Links
Canonical: https://fsome.com/organization/erasca-15767 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.